Early research (Phase 1)Study completedNCT01877226
What this trial is testing
Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants
Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18